Glycemic Control and Variability for Congestive Heart Failure Exacerbation

Completed · Phase 1/Phase 2

Conditions studied: Congestive Heart Failure, Diabetes Mellitus

In brief

High glucose as well as fluctuations (rapid swings) in blood glucose can contribute to severe hospital complications and even death.

Key facts

Study ID

NCT00812487

Run by

Kathleen Dungan

People needed

75

Starts

2009-01-01

Expected to finish

2013-09-01

Last updated by the study team

2013-12-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 and above
• Admitted (less than 48 hours) to the with worsening heart failure
• Hyperglycemia or diabetes. Hyperglycemia is defined as blood glucose greater than 150 mg/dL on at least 2 occasions separated by at least 4 hours apart, insulin use, or HbA1c >6.5%.

You may not qualify if…

• Type 1 diabetes
• Receiving comfort care measures only
• Hospital stay expected to be less than 2 days
• Pregnancy
• Prisoners
• Participation in the study on prior hospitalizations
• Acute myocardial infarction within 3 months
• End stage renal or liver disease

Where it is running

• The Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.